Clinical-stage pharmaceutical company Cempra, Inc. (CEMP) said Wednesday that it has closed its previously announced initial public offering of 8.4 million shares of common stock at $6.00 per share.
The shares began trading on February 3 on The Nasdaq Global Market under the ticker symbol "CEMP."
Total net proceeds to the company from the offering, after deducting underwriter discounts and commissions and estimated offering expenses, were about $47.7 million.
The company plans to use the net proceeds from the offering to develop two of its product candidates, CEM-101 and Taksta.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.